<DOC>
	<DOCNO>NCT02203357</DOCNO>
	<brief_summary>The objective study evaluate immunogenicity Anti-HBV antibody persistence hepatitis B vaccine different dos schedule . Hepatitis B vaccine regimens 20μg , 0-1-6 mon 60μg,0-1 0-2 mon administer young adult , comparative immunogenicity among three group measure 1 mon post-a series vaccination , 1- 2-year first dose regimen . Furthermore , safety hepatitis B vaccine different dos schedule also evaluate .</brief_summary>
	<brief_title>A Randomized , Parallel-group Clinical Trial Hepatitis B Vaccine With Different Dosages Schedules Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy subject age 16 25 establish medical history clinical examination Written inform consent obtain subject serum screen HBV marker Seronegative HBsAg , antiHBs antibody , antiHBc antibody Have never immunize HBV vaccine Subject medical history allergic ingredient vaccine Family history seizure progressive neurological disease Autoimmune disease immunodeficiency Women pregnant Bleeding disorder diagnose doctor Chronic disease : hepatitis , tumor , tuberculosis , et.al Any prior administration immunoglobulin blood product last 3 mon recruitment Subjects medical history serious adverse reaction vaccine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>hepatitis B</keyword>
	<keyword>hepatitis B vaccine</keyword>
	<keyword>immunogenicity</keyword>
	<keyword>adult</keyword>
</DOC>